Economy: Economic News, Policy & Analysis - The Washington Post: Human Genome Sciences rejects $2.59B buyout offer from drugmaker Glaxo

Economy: Economic News, Policy & Analysis - The Washington Post Economy News: Get the latest headlines and in-depth coverage of economic news, policy, analysis and more from The Washington Post.

Human Genome Sciences rejects $2.59B buyout offer from drugmaker Glaxo Apr 19th 2012, 16:45 Rockville-based Human Genome Sciences has rejected a buyout offer from GlaxoSmithKline estimated to be worth $2.59 billion, the company said Thursday. But it said it will explore options with the British drugmaker that could include a sale. Read full article >>

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Tweet